SYK
Stryker Corporation · Healthcare · Medical - Devices
动量输入(同类管理人):
持有人广度 -10.5% ·
股份流向 -1.9% ·
净新建仓位 -11.8%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q1 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +2 | 222.53M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | — | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | — |
| Q2 2024 | 16 | — | 41.27M | $14.03B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 14.81M | +0.2% | $5.52B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 12.13M | +9.2% | $4.52B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 12.13M | +9.2% | $4.52B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 7.31M | +3.4% | $2.71B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 7.31M | +3.4% | $2.71B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 6.40M | -23.7% | $2.38B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 5.08M | +6.8% | $1.89B | 0.3% | ▲ Add | 4 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 3.66M | -10.4% | $1.36B | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 665.30K | +9.6% | $247.66M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 665.30K | +9.6% | $247.66M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 434.85K | -0.3% | $161.87M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 227.63K | +67.8% | $84.73M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 134.35K | -7.0% | $50.01M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 113.80K | +12.6% | $41.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 113.80K | +12.6% | $41.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 113.80K | +12.6% | $41.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 113.80K | +12.6% | $41.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 113.80K | +12.6% | $41.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Millennium Management ✦ | 28.07K | -61.9% | $10.45M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 23.48K | -75.6% | $8.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Marshall Wace ✦ | 22.87K | +688.0% | $8.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Marshall Wace ✦ | 22.87K | +688.0% | $8.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 21.72K | +0.7% | $8.09M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 29 | Bridgewater Associates ✦ | 15.48K | -61.2% | $5.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 30 | Gotham Asset Management ✦ | 9.16K | +115.6% | $3.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $77.14M | 曾为 0.2% |
| Citadel Advisors | $6.53M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 2,274 持有人, 283.44M 股份, $87.41B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Director · 805 股 · $276,495
Director · 80 股 · $26,804
Director · 320 股 · $107,774
Director · 2.31K 股 · $780,062
Director · 11.26K 股 · $3.81M
Director · 10.81K 股 · $3.67M
Director · 16.61K 股 · $5.66M
Director · 3.27K 股 · $1.12M
Director · 3.85K 股 · $1.32M
Director · 40 股 · $13,272
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论